Responding to the FDA Warning and ACOG Statement on NIPT Implications of Prenatal Screening for Down Syndrome in an Evolving Landscape
Main Article Content
Abstract
Non-Invasive Prenatal Testing (NIPT) has become a popular standard of prenatal care as a screening method for Trisomy 21 (Down syndrome). However, there are many shortcomings of the test -- both scientific and ethical. This research paper critically examines the implications of NIPT, arguing against its moral permissibility as a standard test for Down syndrome, even though the FDA and American College of Obstetricians and Gynecologists continue to support its use.
Scientifically, false positives associated with NIPT raise doubts about the accuracy of results and the subsequent decisions made based on them. Moreover, the responses triggered by NIPT outcomes often lead to actions that are either scientifically impossible or ethically impermissible.
Ethically, natural rights and utilitarian theories can be seen as justifications for NIPT. A common thread among these theories and proponents for NIPT is freedom and autonomy. However, liberty based on faulty information is not true freedom nor respect - it is demeaning. Drawing upon natural law theory and Kantianism, I support the argument against NIPT. I demonstrate how NIPT violates the principle of double effect (PDE) within natural law theory and emphasize the importance of human dignity for individuals with Down syndrome from a Kantian perspective.
Ultimately, I will call for a more nuanced approach to prenatal care decision-making that respects principles of accuracy, autonomy, and human dignity for all.
Article Details
References
Marsh, S. (2023, April 25). Barbie doll with Down’s syndrome
launched by Mattel. The Guardian. https://www.theguardian.
com/society/2023/apr/25/barbie-doll-with-downs-syndromelaunched-
by-mattel
The Children’s Hospital of Philadelphia. (2014, August 23).
Trisomy 18 and 13. https://www.chop.edu/conditions-diseases/
trisomy-18-and-13
Cleveland Clinic. (n.d.). NIPT test (Noninvasive prenatal
testing): What to expect. https://my.clevelandclinic.org/health/
diagnostics/21050-nipt-test
Baldus, M. (2023). “Overestimated technology – underestimated
consequences” – reflections on risks, ethical conflicts, and
social disparities in the handling of non-invasive prenatal tests
(NIPTs). Medicine, Health Care and Philosophy. https://doi.
org/10.1007/s11019-023-10143-1
Commissioner of the FDA. (2022, April 20). FDA warns of risks
associated with non-invasive prenatal screening tests. https://
www.fda.gov/news-events/press-announcements/fda-warnsrisks-
associated-non-invasive-prenatal-screening-tests
Witters, G., Van Robays, J., Willekes, C., Coumans, A., Peeters, H.,
Gyselaers, W., & Fryns, J. P. (2011). Trisomy 13, 18, 21, Triploidy
and Turner syndrome: The 5T’s. Look at the hands. Facts, Views
& Vision in ObGyn, 3(1), 15–21. https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3991414/
Skuse, D., Printzlau, F., & Wolstencroft, J. (2018). Sex
chromosome aneuploidies. In Handbook of Clinical Neurology
(Vol. 147, pp. 355–376). Elsevier. https://doi.org/10.1016/B978-
-444-63233-3.00024-5
Medical News Today. (2020, March 25). Mosaic down
syndrome: Definition, symptoms, and diagnosis. https://www.
medicalnewstoday.com/articles/mosaic-down-syndrome
Cleveland Clinic. (n.d.). Chorionic villus sampling (CVS): What
it is, benefits & risks. https://my.clevelandclinic.org/health/
diagnostics/4028-chorionic-villus-sampling-for-prenataldiagnosis
American College of Obstetricians and Gynecologists. (n.d.).
ACOG Statement on FDA NIPT Warning. https://www.acog.org/
en/news/news-releases/2022/04/statement-on-fda-warninggenetic-
non-invasive-prenatal-screening-tests